| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HJV PRLHR FLT3 HTR1A OR9A4 GPR20 PDGFRB FFAR2 OR9Q1 OR4E1 OR6C3 GRIA1 ADGRV1 PTGER2 OR1L3 SORT1 MST1R ADGRG7 OR51B5 CELSR1 GPR153 OR6C76 OR10J4 TNF OR4K3 HCRTR2 | 1.67e-07 | 1353 | 123 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | PRLHR HTR1A OR9A4 GPR20 PDGFRB FFAR2 OR9Q1 OR4E1 OR6C3 ADGRV1 PTGER2 OR1L3 ADGRG7 OR51B5 CELSR1 GPR153 OR6C76 OR10J4 OR4K3 HCRTR2 | 4.54e-07 | 884 | 123 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.08e-07 | 4 | 123 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 2.26e-06 | 5 | 123 | 3 | GO:0031821 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.50e-06 | 6 | 123 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 4.95e-06 | 19 | 123 | 4 | GO:0032794 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 1.57e-05 | 25 | 123 | 4 | GO:0031683 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.79e-05 | 31 | 123 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.74e-04 | 18 | 123 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion binding | AOC1 CDHR2 CDHR3 FAT3 MATN4 ADGRV1 RYR1 RYR2 RYR3 MMRN1 EYS PPP2R3A CELSR1 PCDH15 | 2.13e-04 | 749 | 123 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | antiporter activity | 2.14e-04 | 138 | 123 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.45e-04 | 61 | 123 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 SLC26A5 ATP13A5 ABCA9 SLC30A6 SLC26A8 SLC44A5 RALBP1 ABCC2 SLC25A17 | 7.45e-04 | 477 | 123 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 9.04e-04 | 31 | 123 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.03e-03 | 8 | 123 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.09e-03 | 33 | 123 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.22e-03 | 129 | 123 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.41e-03 | 431 | 123 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.64e-03 | 10 | 123 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.89e-03 | 85 | 123 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.00e-03 | 11 | 123 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 2.35e-03 | 43 | 123 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 SLC26A5 GRIA1 ATP13A5 ABCA9 RYR1 RYR2 RYR3 SLC30A6 GRAMD1B SLC26A8 SIDT2 SLC44A5 RALBP1 NIPAL1 ABCC2 SLC25A17 | 2.36e-03 | 1289 | 123 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 SLC26A5 GRIA1 ATP13A5 ABCA9 RYR1 RYR2 RYR3 SLC30A6 SLC26A8 SIDT2 SLC44A5 RALBP1 NIPAL1 ABCC2 SLC25A17 | 2.42e-03 | 1180 | 123 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.45e-03 | 151 | 123 | 5 | GO:0015085 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | PRLHR HTR1A OR9A4 GPR20 PDGFRB FFAR2 OR9Q1 OR4E1 OR6C3 ADGRV1 PTGER2 OR1L3 SORT1 ADGRG7 OR51B5 CELSR1 GPR153 OR6C76 TENM1 GNAT3 GNAI1 OR10J4 GNAI3 GNAO1 OR4K3 PREX1 HCRTR2 | 3.40e-08 | 1395 | 122 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR9A4 CDHR2 OR9Q1 OR4E1 OR6C3 PRPH2 ADGRV1 OR1L3 RYR2 OR51B5 EYS OR6C76 PCDH15 GNAT3 OR10J4 TNF OR4K3 | 1.22e-06 | 722 | 122 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR9A4 OR9Q1 OR4E1 OR6C3 PRPH2 ADGRV1 OR1L3 OR51B5 EYS OR6C76 PCDH15 GNAT3 OR10J4 TNF OR4K3 | 1.82e-06 | 582 | 122 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | interleukin-33 production | 1.11e-05 | 8 | 122 | 3 | GO:0072639 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.22e-05 | 11 | 122 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.62e-05 | 37 | 122 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 7.01e-05 | 14 | 122 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HJV SLC24A5 GRIA1 ATP13A5 EXT2 RYR1 RYR2 RYR3 CORIN DMD ABCC2 IL1A HCRTR2 | 8.15e-05 | 622 | 122 | 13 | GO:0098771 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 8.16e-05 | 39 | 122 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.32e-04 | 44 | 122 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | HJV SLC24A5 FFAR2 HECTD4 GRIA1 ATP13A5 CPB2 EXT2 RYR1 RYR2 RYR3 GRAMD1B SIDT2 DISP3 CORIN DMD ABCC2 IL1A HCRTR2 | 1.34e-04 | 1249 | 122 | 19 | GO:0048878 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 8.93e-07 | 56 | 122 | 6 | GO:0031234 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.59e-05 | 137 | 122 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 5.03e-05 | 35 | 122 | 4 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 9.46e-05 | 41 | 122 | 4 | GO:1905360 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.08e-04 | 185 | 122 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.67e-04 | 139 | 122 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | cilium | PRLHR PTCHD3 DYNC2H1 STARD10 KIAA1549 PRPH2 ADGRV1 ARHGAP35 SLC26A8 EYS PCDH15 GNAT3 DLEC1 CFAP61 DNAH8 | 2.36e-04 | 898 | 122 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.80e-04 | 153 | 122 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 4.09e-04 | 230 | 122 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.09e-04 | 230 | 122 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PTCHD3 TAPBPL OR4E1 DNAJC18 GRIA1 EXT2 DEGS1 DDOST RYR1 RYR2 RYR3 SORT1 GRAMD1B YIF1B AGMO DISP3 GNAI3 FLRT3 | 5.07e-04 | 1293 | 122 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PTCHD3 TAPBPL OR4E1 DNAJC18 GRIA1 EXT2 DEGS1 DDOST RYR1 RYR2 RYR3 SORT1 GRAMD1B YIF1B AGMO DISP3 GNAI3 FLRT3 | 5.35e-04 | 1299 | 122 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | side of membrane | HJV FLT3 VWF RYR1 RYR2 RYR3 NTM CD33 GNAT3 GNAI1 TNF GNAI3 GNAO1 DMD | 5.89e-04 | 875 | 122 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PTCHD3 TAPBPL OR4E1 DNAJC18 GRIA1 EXT2 DEGS1 DDOST RYR1 RYR2 RYR3 SORT1 GRAMD1B YIF1B AGMO DISP3 GNAI3 FLRT3 | 6.86e-04 | 1327 | 122 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | meiotic cohesin complex | 6.96e-04 | 7 | 122 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.03e-03 | 196 | 122 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 1.18e-03 | 9 | 122 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.18e-03 | 9 | 122 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.47e-03 | 10 | 122 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | cohesin complex | 1.80e-03 | 11 | 122 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | Z disc | 1.94e-03 | 151 | 122 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | cell surface | HJV FLT3 VWF PDGFRB GRIA1 ADGRV1 SORT1 MST1R NTM CD33 CORIN TNF DMD ABCC2 IL1A | 2.07e-03 | 1111 | 122 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.30e-03 | 45 | 122 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.45e-03 | 46 | 122 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | I band | 2.92e-03 | 166 | 122 | 5 | GO:0031674 | |
| Domain | Gprotein_alpha_I | 9.70e-08 | 8 | 116 | 4 | IPR001408 | |
| Domain | ConA-like_dom | COL12A1 FAT3 LAMA1 ADGRV1 RYR1 RYR2 RYR3 MMRN1 EYS CELSR1 HERC1 | 1.20e-07 | 219 | 116 | 11 | IPR013320 |
| Domain | Ryanrecept_TM4-6 | 2.33e-07 | 3 | 116 | 3 | IPR009460 | |
| Domain | RyR | 2.33e-07 | 3 | 116 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.33e-07 | 3 | 116 | 3 | IPR003032 | |
| Domain | RR_TM4-6 | 2.33e-07 | 3 | 116 | 3 | PF06459 | |
| Domain | Ryan_recept | 2.33e-07 | 3 | 116 | 3 | IPR013333 | |
| Domain | G-alpha | 2.43e-06 | 16 | 116 | 4 | PF00503 | |
| Domain | GproteinA_insert | 2.43e-06 | 16 | 116 | 4 | IPR011025 | |
| Domain | - | 2.43e-06 | 16 | 116 | 4 | 1.10.400.10 | |
| Domain | G_alpha | 2.43e-06 | 16 | 116 | 4 | SM00275 | |
| Domain | Gprotein_alpha_su | 3.16e-06 | 17 | 116 | 4 | IPR001019 | |
| Domain | RIH_assoc | 4.61e-06 | 6 | 116 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 4.61e-06 | 6 | 116 | 3 | IPR013662 | |
| Domain | RIH_dom | 4.61e-06 | 6 | 116 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.61e-06 | 6 | 116 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.61e-06 | 6 | 116 | 3 | IPR015925 | |
| Domain | - | 4.61e-06 | 6 | 116 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.61e-06 | 6 | 116 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 4.61e-06 | 6 | 116 | 3 | PF08709 | |
| Domain | MIR | 2.71e-05 | 10 | 116 | 3 | PS50919 | |
| Domain | MIR | 2.71e-05 | 10 | 116 | 3 | PF02815 | |
| Domain | MIR | 2.71e-05 | 10 | 116 | 3 | SM00472 | |
| Domain | MIR_motif | 2.71e-05 | 10 | 116 | 3 | IPR016093 | |
| Domain | - | 2.79e-05 | 95 | 116 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 2.99e-05 | 58 | 116 | 5 | IPR001791 | |
| Domain | CA | 8.18e-05 | 115 | 116 | 6 | SM00112 | |
| Domain | LAM_G_DOMAIN | 8.86e-05 | 38 | 116 | 4 | PS50025 | |
| Domain | Cadherin | 9.43e-05 | 118 | 116 | 6 | IPR002126 | |
| Domain | Laminin_G_2 | 1.09e-04 | 40 | 116 | 4 | PF02210 | |
| Domain | LamG | 1.58e-04 | 44 | 116 | 4 | SM00282 | |
| Domain | GPCR_Rhodpsn_7TM | PRLHR HTR1A OR9A4 GPR20 FFAR2 OR9Q1 OR6C3 PTGER2 OR1L3 OR51B5 GPR153 OR6C76 HCRTR2 | 2.68e-04 | 670 | 116 | 13 | IPR017452 |
| Domain | 7tm_1 | PRLHR HTR1A OR9A4 GPR20 FFAR2 OR9Q1 OR6C3 PTGER2 OR1L3 OR51B5 GPR153 OR6C76 HCRTR2 | 2.96e-04 | 677 | 116 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | PRLHR HTR1A OR9A4 GPR20 FFAR2 OR9Q1 OR6C3 PTGER2 OR1L3 OR51B5 GPR153 OR6C76 HCRTR2 | 3.32e-04 | 685 | 116 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | PRLHR HTR1A OR9A4 GPR20 FFAR2 OR9Q1 OR6C3 PTGER2 OR1L3 OR51B5 GPR153 OR6C76 HCRTR2 | 3.61e-04 | 691 | 116 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | PRLHR HTR1A OR9A4 GPR20 FFAR2 OR9Q1 OR6C3 PTGER2 OR1L3 OR51B5 GPR153 OR6C76 HCRTR2 | 3.66e-04 | 692 | 116 | 13 | IPR000276 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.21e-04 | 106 | 116 | 5 | IPR000152 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 5.64e-04 | 6 | 116 | 2 | IPR016243 | |
| Domain | EGF | 6.66e-04 | 235 | 116 | 7 | SM00181 | |
| Domain | CADHERIN_1 | 6.98e-04 | 113 | 116 | 5 | PS00232 | |
| Domain | Cadherin | 6.98e-04 | 113 | 116 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 7.26e-04 | 114 | 116 | 5 | PS50268 | |
| Domain | - | 7.26e-04 | 114 | 116 | 5 | 2.60.40.60 | |
| Domain | Cadherin-like | 7.86e-04 | 116 | 116 | 5 | IPR015919 | |
| Domain | EGF-like_dom | 9.35e-04 | 249 | 116 | 7 | IPR000742 | |
| Domain | EGF_CA | 9.86e-04 | 122 | 116 | 5 | SM00179 | |
| Domain | Calx_beta | 1.04e-03 | 8 | 116 | 2 | SM00237 | |
| Domain | Tyr_kinase_rcpt_3_CS | 1.04e-03 | 8 | 116 | 2 | IPR001824 | |
| Domain | DHC_N1 | 1.04e-03 | 8 | 116 | 2 | PF08385 | |
| Domain | RECEPTOR_TYR_KIN_III | 1.04e-03 | 8 | 116 | 2 | PS00240 | |
| Domain | Dynein_heavy_dom-1 | 1.04e-03 | 8 | 116 | 2 | IPR013594 | |
| Domain | EGF-like_Ca-bd_dom | 1.06e-03 | 124 | 116 | 5 | IPR001881 | |
| Domain | EGF_1 | 1.07e-03 | 255 | 116 | 7 | PS00022 | |
| Domain | ig | 1.20e-03 | 190 | 116 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.20e-03 | 190 | 116 | 6 | IPR013151 | |
| Domain | GPS | 1.21e-03 | 34 | 116 | 3 | SM00303 | |
| Domain | EGF-like_CS | 1.23e-03 | 261 | 116 | 7 | IPR013032 | |
| Domain | GPS | 1.32e-03 | 35 | 116 | 3 | PF01825 | |
| Domain | Calx_beta | 1.34e-03 | 9 | 116 | 2 | IPR003644 | |
| Domain | Ptc/Disp | 1.34e-03 | 9 | 116 | 2 | IPR003392 | |
| Domain | Patched | 1.34e-03 | 9 | 116 | 2 | PF02460 | |
| Domain | Calx-beta | 1.34e-03 | 9 | 116 | 2 | PF03160 | |
| Domain | EGF_2 | 1.34e-03 | 265 | 116 | 7 | PS01186 | |
| Domain | GPS | 1.44e-03 | 36 | 116 | 3 | PS50221 | |
| Domain | GPS | 1.56e-03 | 37 | 116 | 3 | IPR000203 | |
| Domain | SLC26A | 1.67e-03 | 10 | 116 | 2 | PS01130 | |
| Domain | STAS | 2.03e-03 | 11 | 116 | 2 | PS50801 | |
| Domain | STAS_dom | 2.03e-03 | 11 | 116 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.03e-03 | 11 | 116 | 2 | IPR011547 | |
| Domain | STAS | 2.03e-03 | 11 | 116 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 2.03e-03 | 11 | 116 | 2 | IPR001902 | |
| Domain | Laminin_G_1 | 2.03e-03 | 11 | 116 | 2 | PF00054 | |
| Domain | - | 2.03e-03 | 11 | 116 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.03e-03 | 11 | 116 | 2 | PF00916 | |
| Domain | SPRY | 2.12e-03 | 87 | 116 | 4 | SM00449 | |
| Domain | SPRY | 2.80e-03 | 94 | 116 | 4 | PF00622 | |
| Domain | SPRY_dom | 2.80e-03 | 94 | 116 | 4 | IPR003877 | |
| Domain | SSD | 2.85e-03 | 13 | 116 | 2 | IPR000731 | |
| Domain | SSD | 2.85e-03 | 13 | 116 | 2 | PS50156 | |
| Domain | B30.2/SPRY | 2.91e-03 | 95 | 116 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.91e-03 | 95 | 116 | 4 | PS50188 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.31e-03 | 14 | 116 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.31e-03 | 14 | 116 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.31e-03 | 14 | 116 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.31e-03 | 14 | 116 | 2 | PF08393 | |
| Domain | MT | 3.31e-03 | 14 | 116 | 2 | PF12777 | |
| Domain | AAA_8 | 3.31e-03 | 14 | 116 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.31e-03 | 14 | 116 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.31e-03 | 14 | 116 | 2 | PF07728 | |
| Domain | EGF_3 | 3.50e-03 | 235 | 116 | 6 | PS50026 | |
| Domain | ASX_HYDROXYL | 3.50e-03 | 100 | 116 | 4 | PS00010 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.70e-03 | 50 | 116 | 3 | PS00650 | |
| Domain | 7tm_2 | 3.70e-03 | 50 | 116 | 3 | PF00002 | |
| Domain | ABC_transporter-like | 3.70e-03 | 50 | 116 | 3 | IPR003439 | |
| Domain | DHC_fam | 3.81e-03 | 15 | 116 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.81e-03 | 15 | 116 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.81e-03 | 15 | 116 | 2 | PF03028 | |
| Domain | Cadherin_CS | 4.76e-03 | 109 | 116 | 4 | IPR020894 | |
| Domain | VWA | 5.09e-03 | 56 | 116 | 3 | PF00092 | |
| Domain | 7TM_GPCR_Srsx | 5.24e-03 | 112 | 116 | 4 | SM01381 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.32e-06 | 13 | 95 | 4 | M39589 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 1.06e-05 | 21 | 95 | 4 | M103 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 4.04e-05 | 29 | 95 | 4 | M55 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.70e-05 | 11 | 95 | 3 | M47958 | |
| Pathway | WP_PURINERGIC_SIGNALING | 6.82e-05 | 33 | 95 | 4 | M39855 | |
| Pathway | WP_IRON_HOMEOSTASIS | 8.07e-05 | 13 | 95 | 3 | MM15935 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-04 | 14 | 95 | 3 | MM14669 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 1.02e-04 | 14 | 95 | 3 | M64 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-04 | 14 | 95 | 3 | M750 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.07e-04 | 70 | 95 | 5 | M8232 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.08e-04 | 37 | 95 | 4 | M42558 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.66e-04 | 19 | 95 | 3 | M47760 | |
| Pathway | PID_S1P_META_PATHWAY | 3.61e-04 | 21 | 95 | 3 | M155 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 4.16e-04 | 22 | 95 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 4.16e-04 | 22 | 95 | 3 | M841 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.71e-04 | 147 | 95 | 6 | MM15854 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 5.42e-04 | 24 | 95 | 3 | M268 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.43e-04 | 151 | 95 | 6 | M39329 | |
| Pathway | PID_SHP2_PATHWAY | 5.82e-04 | 57 | 95 | 4 | M100 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 6.62e-04 | 6 | 95 | 2 | M22069 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 6.89e-04 | 26 | 95 | 3 | M47553 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 9.23e-04 | 7 | 95 | 2 | MM1580 | |
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 3.08e-08 | 10 | 123 | 4 | 8521505 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 18403125 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.32e-08 | 3 | 123 | 3 | 9204703 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 4.32e-08 | 3 | 123 | 3 | 12213830 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 25239916 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 11159936 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 7959768 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 7635066 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 7876312 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.32e-08 | 3 | 123 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.32e-08 | 3 | 123 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.32e-08 | 3 | 123 | 3 | 10473538 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 9242641 | ||
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 18643873 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 4.32e-08 | 3 | 123 | 3 | 4600883 | |
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 1.04e-07 | 13 | 123 | 4 | 8208289 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 1.04e-07 | 13 | 123 | 4 | 16892066 | |
| Pubmed | SMG1 STARD10 DNAJC18 GRIA1 RYR2 NUP205 SNX25 ASPM TENM1 CEP295 GNAI1 DLEC1 GNAI3 GNAO1 DMD ABCC2 TMPRSS7 SPEN DNAH8 PREX1 | 1.70e-07 | 1442 | 123 | 20 | 35575683 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.72e-07 | 4 | 123 | 3 | 23413940 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9607712 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 23482488 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 10364213 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 1.72e-07 | 4 | 123 | 3 | 11248120 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 18206662 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 11771389 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9384575 | ||
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 1.72e-07 | 4 | 123 | 3 | 18832081 | |
| Pubmed | 1.97e-07 | 15 | 123 | 4 | 11118617 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 4.29e-07 | 5 | 123 | 3 | 19011160 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12860983 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 23918386 | ||
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 4.29e-07 | 5 | 123 | 3 | 2820999 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12711604 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 19549818 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.57e-07 | 6 | 123 | 3 | 25966694 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 25078664 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 20519450 | ||
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 8.57e-07 | 6 | 123 | 3 | 11253162 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.57e-07 | 6 | 123 | 3 | 26025922 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 8.57e-07 | 6 | 123 | 3 | 14592808 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.57e-07 | 6 | 123 | 3 | 16844763 | |
| Pubmed | 1.16e-06 | 52 | 123 | 5 | 8288218 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 15251452 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 20962236 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 8986788 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 11860456 | ||
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 2.39e-06 | 8 | 123 | 3 | 12509430 | |
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.39e-06 | 8 | 123 | 3 | 19033399 | |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 3.57e-06 | 9 | 123 | 3 | 38651641 | |
| Pubmed | Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. | 3.57e-06 | 9 | 123 | 3 | 27661418 | |
| Pubmed | 5.09e-06 | 10 | 123 | 3 | 18434328 | ||
| Pubmed | 5.09e-06 | 10 | 123 | 3 | 26755700 | ||
| Pubmed | 5.09e-06 | 10 | 123 | 3 | 8552586 | ||
| Pubmed | 5.63e-06 | 33 | 123 | 4 | 24204828 | ||
| Pubmed | 6.98e-06 | 11 | 123 | 3 | 26952749 | ||
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 9.28e-06 | 12 | 123 | 3 | 2508088 | |
| Pubmed | 9.28e-06 | 12 | 123 | 3 | 19095005 | ||
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 9.28e-06 | 12 | 123 | 3 | 10926822 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23100272 | ||
| Pubmed | Genetic polymorphisms of TNFA and IL-1A and generalized aggressive periodontitis. | 1.24e-05 | 2 | 123 | 2 | 26193214 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 26555638 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19175495 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12112371 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 36048129 | ||
| Pubmed | Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. | 1.24e-05 | 2 | 123 | 2 | 12929194 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9489997 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 11053690 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.24e-05 | 2 | 123 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.24e-05 | 2 | 123 | 2 | 26009179 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16564703 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8898078 | ||
| Pubmed | DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism. | 1.24e-05 | 2 | 123 | 2 | 37742307 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22998440 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 14550562 | ||
| Pubmed | Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting. | 1.24e-05 | 2 | 123 | 2 | 30884219 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 32766788 | ||
| Pubmed | Differentiation of human T cells alters their repertoire of G protein alpha-subunits. | 1.24e-05 | 2 | 123 | 2 | 20829352 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 33754034 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.24e-05 | 2 | 123 | 2 | 15033925 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8218170 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.24e-05 | 2 | 123 | 2 | 17118445 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21435454 | ||
| Pubmed | Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice. | 1.24e-05 | 2 | 123 | 2 | 9302549 | |
| Pubmed | Altered cohesin gene dosage affects Mammalian meiotic chromosome structure and behavior. | 1.24e-05 | 2 | 123 | 2 | 23408896 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.24e-05 | 2 | 123 | 2 | 21531043 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17229632 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19242504 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16678258 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12565913 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9192302 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 34610045 | ||
| Pubmed | ZEB1 protects skeletal muscle from damage and is required for its regeneration. | 1.24e-05 | 2 | 123 | 2 | 30910999 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 7556644 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8107314 | ||
| Interaction | ADAMTS13 interactions | 3.61e-07 | 26 | 117 | 5 | int:ADAMTS13 | |
| Interaction | XAGE1A interactions | 3.84e-06 | 41 | 117 | 5 | int:XAGE1A | |
| Interaction | C2CD4B interactions | 5.48e-06 | 44 | 117 | 5 | int:C2CD4B | |
| Interaction | UCN3 interactions | 8.77e-06 | 23 | 117 | 4 | int:UCN3 | |
| Interaction | CHN2 interactions | 2.16e-05 | 97 | 117 | 6 | int:CHN2 | |
| Interaction | PRICKLE2 interactions | 3.01e-05 | 62 | 117 | 5 | int:PRICKLE2 | |
| Interaction | ZBBX interactions | 3.01e-05 | 31 | 117 | 4 | int:ZBBX | |
| Interaction | RGS5 interactions | 4.04e-05 | 12 | 117 | 3 | int:RGS5 | |
| Interaction | S1PR1 interactions | 4.88e-05 | 112 | 117 | 6 | int:S1PR1 | |
| Interaction | LPXN interactions | 5.66e-05 | 115 | 117 | 6 | int:LPXN | |
| Interaction | LOC254896 interactions | 1.12e-04 | 43 | 117 | 4 | int:LOC254896 | |
| Interaction | RGS16 interactions | 1.22e-04 | 17 | 117 | 3 | int:RGS16 | |
| Interaction | LAG3 interactions | 1.22e-04 | 17 | 117 | 3 | int:LAG3 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 9.67e-08 | 3 | 84 | 3 | 287 | |
| GeneFamily | Cadherin related | 9.85e-07 | 17 | 84 | 4 | 24 | |
| GeneFamily | Cohesin complex | 5.86e-04 | 8 | 84 | 2 | 1060 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.44e-04 | 40 | 84 | 3 | 321 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | FAT3 LAMA1 DNAJC18 CPB2 DDOST SORT1 FREM2 ARHGEF7 NTM CORIN DMD TMEM255A | 4.92e-08 | 293 | 112 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | COL12A1 GINM1 PDGFRB FAT3 LAMA1 DNAJC18 CPB2 DDOST SORT1 FREM2 ARHGEF7 NTM CORIN GNAO1 DMD ABCC2 TMEM255A | 5.19e-06 | 905 | 112 | 17 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 FAT3 LAMA1 ADGRV1 RYR2 RYR3 FREM2 PCDH15 TENM1 DISP3 DMD UNC79 | 1.34e-13 | 184 | 122 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 FAT3 LAMA1 ADGRV1 RYR2 RYR3 FREM2 PCDH15 TENM1 DISP3 DMD UNC79 | 1.34e-13 | 184 | 122 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 FAT3 LAMA1 ADGRV1 RYR2 RYR3 FREM2 PCDH15 TENM1 DISP3 DMD UNC79 | 1.34e-13 | 184 | 122 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.94e-10 | 159 | 122 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-10 | 162 | 122 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-09 | 145 | 122 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-08 | 187 | 122 | 8 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-08 | 187 | 122 | 8 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.13e-08 | 188 | 122 | 8 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.13e-08 | 188 | 122 | 8 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.27e-08 | 200 | 122 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-07 | 160 | 122 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-07 | 160 | 122 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.40e-07 | 163 | 122 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-07 | 169 | 122 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-07 | 177 | 122 | 7 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-07 | 179 | 122 | 7 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.15e-07 | 182 | 122 | 7 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-07 | 186 | 122 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-07 | 188 | 122 | 7 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.88e-07 | 188 | 122 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.88e-07 | 188 | 122 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-07 | 188 | 122 | 7 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.53e-07 | 190 | 122 | 7 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-07 | 190 | 122 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.88e-07 | 191 | 122 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-07 | 191 | 122 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-07 | 191 | 122 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-07 | 191 | 122 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 192 | 122 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 192 | 122 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.02e-06 | 192 | 122 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 193 | 122 | 7 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.13e-06 | 195 | 122 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 196 | 122 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-06 | 196 | 122 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-06 | 198 | 122 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.34e-06 | 200 | 122 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.34e-06 | 200 | 122 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-06 | 200 | 122 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-06 | 200 | 122 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-06 | 144 | 122 | 6 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.25e-06 | 154 | 122 | 6 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 156 | 122 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 156 | 122 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.93e-06 | 158 | 122 | 6 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.93e-06 | 158 | 122 | 6 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.93e-06 | 158 | 122 | 6 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.11e-06 | 159 | 122 | 6 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.49e-06 | 161 | 122 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.32e-06 | 165 | 122 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.32e-06 | 165 | 122 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 165 | 122 | 6 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.32e-06 | 165 | 122 | 6 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 165 | 122 | 6 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.49e-06 | 170 | 122 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 173 | 122 | 6 | 2eb6e9fc3a3654f6f86fbd112e80a18814afd103 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.84e-06 | 175 | 122 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-06 | 175 | 122 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-06 | 175 | 122 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.84e-06 | 175 | 122 | 6 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 179 | 122 | 6 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 180 | 122 | 6 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 181 | 122 | 6 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 181 | 122 | 6 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-05 | 182 | 122 | 6 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-05 | 182 | 122 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-05 | 182 | 122 | 6 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 182 | 122 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-05 | 182 | 122 | 6 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 182 | 122 | 6 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.14e-05 | 183 | 122 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 183 | 122 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.14e-05 | 183 | 122 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 184 | 122 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 184 | 122 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-05 | 186 | 122 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 186 | 122 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 186 | 122 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 186 | 122 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.29e-05 | 187 | 122 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.29e-05 | 187 | 122 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 188 | 122 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 188 | 122 | 6 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.37e-05 | 189 | 122 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 189 | 122 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 189 | 122 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 189 | 122 | 6 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 189 | 122 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-05 | 190 | 122 | 6 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-05 | 190 | 122 | 6 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.41e-05 | 190 | 122 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 122 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 122 | 6 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 122 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 122 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 122 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 122 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-05 | 191 | 122 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| Drug | Azumoleno | 2.45e-08 | 7 | 119 | 4 | CID000056259 | |
| Drug | cis-diammineplatinum(II | 1.39e-07 | 3 | 119 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.39e-07 | 3 | 119 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 1.39e-07 | 3 | 119 | 3 | CID000127713 | |
| Drug | aminodantrolene | 1.39e-07 | 3 | 119 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.39e-07 | 3 | 119 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.39e-07 | 3 | 119 | 3 | CID005748312 | |
| Drug | PCB74 | 5.55e-07 | 4 | 119 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 5.55e-07 | 4 | 119 | 3 | CID006444275 | |
| Drug | SC 38249 | 5.55e-07 | 4 | 119 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 5.55e-07 | 4 | 119 | 3 | CID000035682 | |
| Drug | thiopental | 2.05e-06 | 112 | 119 | 7 | CID003000715 | |
| Drug | chloro-m-cresol | 2.75e-06 | 6 | 119 | 3 | CID000012008 | |
| Drug | MBED | 2.75e-06 | 6 | 119 | 3 | CID000129958 | |
| Drug | AC1O528X | 2.75e-06 | 6 | 119 | 3 | CID006475857 | |
| Drug | NSC114784 | 2.75e-06 | 6 | 119 | 3 | CID000419425 | |
| Drug | indo-1/AM | 3.96e-06 | 21 | 119 | 4 | CID000123918 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 4.80e-06 | 7 | 119 | 3 | CID009547999 | |
| Drug | vadimezan | 4.80e-06 | 7 | 119 | 3 | ctd:C066668 | |
| Drug | Br2BAPTA | 4.80e-06 | 7 | 119 | 3 | CID003081001 | |
| Drug | rhod-2 | 1.32e-05 | 28 | 119 | 4 | CID000123669 | |
| Drug | PCB 95 | 1.63e-05 | 10 | 119 | 3 | CID000038012 | |
| Drug | Guanabenz | 1.63e-05 | 10 | 119 | 3 | ctd:D006143 | |
| Drug | 2,4-xylidinothiazoline | 1.75e-05 | 30 | 119 | 4 | CID000099296 | |
| Drug | PCB 66 | 2.23e-05 | 11 | 119 | 3 | CID000036185 | |
| Drug | R 478 | 2.23e-05 | 11 | 119 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.23e-05 | 11 | 119 | 3 | CID003081323 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 2.71e-05 | 2 | 119 | 2 | ctd:C005147 | |
| Drug | diallyldimethylammonium chloride | 2.71e-05 | 2 | 119 | 2 | CID000033286 | |
| Drug | RCF-1 fiber | 2.71e-05 | 2 | 119 | 2 | ctd:C103119 | |
| Drug | poly(hexamethylenebiguanidinium) | 2.71e-05 | 2 | 119 | 2 | ctd:C107145 | |
| Drug | Mineral Fibers | 2.71e-05 | 2 | 119 | 2 | ctd:D019016 | |
| Drug | Ryanodine | 2.96e-05 | 12 | 119 | 3 | ctd:D012433 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 4.10e-05 | 37 | 119 | 4 | CID000009643 | |
| Drug | FPL 64176 | 6.05e-05 | 15 | 119 | 3 | CID000003423 | |
| Drug | tandutinib | 6.05e-05 | 15 | 119 | 3 | CID003038522 | |
| Drug | Gvapspat amide | 6.05e-05 | 15 | 119 | 3 | CID000125015 | |
| Drug | Dantrolene | 6.19e-05 | 41 | 119 | 4 | ctd:D003620 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 5523_DN | |
| Drug | titanium nitride | 8.10e-05 | 3 | 119 | 2 | ctd:C041500 | |
| Drug | notoginsenoside-R4 | 8.10e-05 | 3 | 119 | 2 | CID005320225 | |
| Drug | Demeclocycline | 8.10e-05 | 3 | 119 | 2 | ctd:D003707 | |
| Drug | potassium octatitanate | 8.10e-05 | 3 | 119 | 2 | ctd:C021028 | |
| Drug | chloroquinoline | 8.10e-05 | 3 | 119 | 2 | CID000011928 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 8.10e-05 | 3 | 119 | 2 | CID000080262 | |
| Drug | flubendiamide | 8.10e-05 | 3 | 119 | 2 | CID011193251 | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 3170_UP | |
| Drug | 4,4'-dithiodipyridine | 8.96e-05 | 45 | 119 | 4 | CID000075846 | |
| Drug | kazinol B | 8.97e-05 | 17 | 119 | 3 | CID000480869 | |
| Drug | methylcoumarin | 1.07e-04 | 18 | 119 | 3 | CID000007092 | |
| Drug | ts M | 1.16e-04 | 48 | 119 | 4 | CID000428025 | |
| Drug | Dantrolene-13C3 | 1.16e-04 | 145 | 119 | 6 | CID000002951 | |
| Drug | AC1MW7VF | 1.27e-04 | 19 | 119 | 3 | CID000414699 | |
| Drug | AC1L380G | 1.27e-04 | 19 | 119 | 3 | CID000084698 | |
| Drug | P-Mo | 1.36e-04 | 50 | 119 | 4 | CID000446492 | |
| Drug | ginsenoside Rc | 1.49e-04 | 20 | 119 | 3 | CID000100018 | |
| Drug | Baclofen | 1.49e-04 | 20 | 119 | 3 | ctd:D001418 | |
| Drug | isotetrandrine | 1.57e-04 | 97 | 119 | 5 | CID000005422 | |
| Drug | A-30 | 1.61e-04 | 4 | 119 | 2 | CID003028528 | |
| Drug | prednisolone 17-ethylcarbonate | 1.61e-04 | 4 | 119 | 2 | CID000128526 | |
| Drug | Bastadin 10 | 1.61e-04 | 4 | 119 | 2 | CID009589366 | |
| Drug | indo-1 | 1.73e-04 | 99 | 119 | 5 | CID000105060 | |
| Drug | CHAPS detergent | 1.85e-04 | 158 | 119 | 6 | CID000107670 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.74e-08 | 8 | 119 | 4 | DOID:1858 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.40e-08 | 3 | 119 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.40e-08 | 3 | 119 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Tactile Amnesia | 4.17e-05 | 17 | 119 | 3 | C0750906 | |
| Disease | Amnestic State | 4.17e-05 | 17 | 119 | 3 | C0750907 | |
| Disease | Dissociative Amnesia | 4.17e-05 | 17 | 119 | 3 | C0236795 | |
| Disease | Hysterical amnesia | 4.17e-05 | 17 | 119 | 3 | C0233750 | |
| Disease | Temporary Amnesia | 4.17e-05 | 17 | 119 | 3 | C0233796 | |
| Disease | Amnesia | 4.17e-05 | 17 | 119 | 3 | C0002622 | |
| Disease | Global Amnesia | 4.17e-05 | 17 | 119 | 3 | C0262497 | |
| Disease | complement factor H-related protein 3 measurement | 6.57e-05 | 169 | 119 | 6 | EFO_0600056 | |
| Disease | HIV Wasting Syndrome | 9.63e-05 | 4 | 119 | 2 | C0343755 | |
| Disease | Hyperbilirubinemia | 9.63e-05 | 4 | 119 | 2 | C0020433 | |
| Disease | lung disease severity measurement | 1.19e-04 | 118 | 119 | 5 | EFO_0007744 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 1.55e-04 | 26 | 119 | 3 | EFO_0010366 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 1.55e-04 | 26 | 119 | 3 | EFO_0007870 | |
| Disease | Polymyositis, Idiopathic | 1.60e-04 | 5 | 119 | 2 | C0554591 | |
| Disease | Polymyositis Ossificans | 1.60e-04 | 5 | 119 | 2 | C0263984 | |
| Disease | Polymyositis | 1.60e-04 | 5 | 119 | 2 | C0085655 | |
| Disease | Fever | 1.74e-04 | 27 | 119 | 3 | C0015967 | |
| Disease | Disorder of eye | 2.27e-04 | 212 | 119 | 6 | C0015397 | |
| Disease | aspiration pneumonia (biomarker_via_orthology) | 2.39e-04 | 6 | 119 | 2 | DOID:0050152 (biomarker_via_orthology) | |
| Disease | Dermatomyositis, Childhood Type | 2.39e-04 | 6 | 119 | 2 | C0263666 | |
| Disease | hemochromatosis (is_implicated_in) | 2.39e-04 | 6 | 119 | 2 | DOID:2352 (is_implicated_in) | |
| Disease | Adult type dermatomyositis | 2.39e-04 | 6 | 119 | 2 | C0221056 | |
| Disease | Dermatomyositis | 2.39e-04 | 6 | 119 | 2 | C0011633 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 2.45e-04 | 75 | 119 | 4 | EFO_0007006, EFO_0009262 | |
| Disease | glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0800520 | |
| Disease | age-related hearing impairment | 3.54e-04 | 324 | 119 | 7 | EFO_0005782 | |
| Disease | opioid dependence | 4.11e-04 | 237 | 119 | 6 | EFO_0005611 | |
| Disease | Cholestasis of pregnancy | 4.44e-04 | 8 | 119 | 2 | C0268318 | |
| Disease | vitiligo (is_marker_for) | 4.44e-04 | 8 | 119 | 2 | DOID:12306 (is_marker_for) | |
| Disease | Anthracosis | 4.44e-04 | 8 | 119 | 2 | C0003165 | |
| Disease | Ventricular Dysfunction | 4.44e-04 | 8 | 119 | 2 | C0242973 | |
| Disease | lymphoid leukemia | 4.87e-04 | 38 | 119 | 3 | EFO_0004289 | |
| Disease | asthma exacerbation measurement | 5.57e-04 | 93 | 119 | 4 | EFO_0007614 | |
| Disease | Colorectal Carcinoma | LAMA1 STK32C ADAMTSL3 ABCA9 LRRC3B TENM1 TNF DMD ABCC2 DNAH8 | 5.66e-04 | 702 | 119 | 10 | C0009402 |
| Disease | Megaconial Myopathies | 5.70e-04 | 9 | 119 | 2 | C0162668 | |
| Disease | Pleoconial Myopathies | 5.70e-04 | 9 | 119 | 2 | C0162669 | |
| Disease | glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 5.70e-04 | 9 | 119 | 2 | EFO_0800476 | |
| Disease | Luft Disease | 5.70e-04 | 9 | 119 | 2 | C0949496 | |
| Disease | cerebrospinal fluid biomarker measurement | 6.28e-04 | 96 | 119 | 4 | EFO_0006794 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0008200 | |
| Disease | status epilepticus (biomarker_via_orthology) | 7.32e-04 | 100 | 119 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Myocardial Ischemia | 7.53e-04 | 176 | 119 | 5 | C0151744 | |
| Disease | Thrombus | 8.55e-04 | 46 | 119 | 3 | C0087086 | |
| Disease | Diabetic Cardiomyopathies | 8.66e-04 | 11 | 119 | 2 | C0853897 | |
| Disease | Mitochondrial Myopathies | 8.66e-04 | 11 | 119 | 2 | C0162670 | |
| Disease | Hemolytic-Uremic Syndrome | 8.66e-04 | 11 | 119 | 2 | C0019061 | |
| Disease | visual epilepsy (is_implicated_in) | 8.66e-04 | 11 | 119 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Thrombosis | 1.03e-03 | 49 | 119 | 3 | C0040053 | |
| Disease | Hereditary hemochromatosis | 1.04e-03 | 12 | 119 | 2 | C0392514 | |
| Disease | Hemochromatosis | 1.04e-03 | 12 | 119 | 2 | C0018995 | |
| Disease | Ciliopathies | 1.04e-03 | 110 | 119 | 4 | C4277690 | |
| Disease | Cholestasis | 1.04e-03 | 110 | 119 | 4 | C0008370 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.19e-03 | 195 | 119 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Graves ophthalmopathy (is_marker_for) | 1.22e-03 | 13 | 119 | 2 | DOID:0081120 (is_marker_for) | |
| Disease | Drug habituation | 1.23e-03 | 115 | 119 | 4 | C0013170 | |
| Disease | Drug abuse | 1.23e-03 | 115 | 119 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.23e-03 | 115 | 119 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.23e-03 | 115 | 119 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.23e-03 | 115 | 119 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.23e-03 | 115 | 119 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.23e-03 | 115 | 119 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.23e-03 | 115 | 119 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.23e-03 | 115 | 119 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.27e-03 | 116 | 119 | 4 | C0740858 | |
| Disease | Hypotension | 1.29e-03 | 53 | 119 | 3 | C0020649 | |
| Disease | diabetic retinopathy (is_marker_for) | 1.37e-03 | 54 | 119 | 3 | DOID:8947 (is_marker_for) | |
| Disease | interleukin-1 beta measurement | 1.37e-03 | 54 | 119 | 3 | EFO_0004812 | |
| Disease | oral cavity cancer | 1.42e-03 | 14 | 119 | 2 | EFO_0005570 | |
| Disease | Muscular Atrophy | 1.64e-03 | 15 | 119 | 2 | C0026846 | |
| Disease | Neurogenic Muscular Atrophy | 1.64e-03 | 15 | 119 | 2 | C0270948 | |
| Disease | Withdrawal Symptoms | 1.68e-03 | 58 | 119 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.68e-03 | 58 | 119 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.68e-03 | 58 | 119 | 3 | C0038587 | |
| Disease | melanoma | 1.72e-03 | 126 | 119 | 4 | EFO_0000756 | |
| Disease | amino acid measurement | 1.74e-03 | 678 | 119 | 9 | EFO_0005134 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 1.87e-03 | 16 | 119 | 2 | DOID:10964 (is_marker_for) | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 1.87e-03 | 16 | 119 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | pulmonary fibrosis (is_implicated_in) | 1.87e-03 | 16 | 119 | 2 | DOID:3770 (is_implicated_in) | |
| Disease | Cardiomyopathies | 1.93e-03 | 130 | 119 | 4 | C0878544 | |
| Disease | disease progression measurement | 1.94e-03 | 61 | 119 | 3 | EFO_0008336 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 2.03e-03 | 62 | 119 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | Vitiligo | 2.11e-03 | 17 | 119 | 2 | C0042900 | |
| Disease | otitis media (biomarker_via_orthology) | 2.11e-03 | 17 | 119 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Oral Submucous Fibrosis | 2.37e-03 | 18 | 119 | 2 | C0029172 | |
| Disease | Tachycardia | 2.37e-03 | 18 | 119 | 2 | C0039231 | |
| Disease | spine bone size | 2.37e-03 | 18 | 119 | 2 | EFO_0004508 | |
| Disease | Tachyarrhythmia | 2.37e-03 | 18 | 119 | 2 | C0080203 | |
| Disease | Grand Mal Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.54e-03 | 67 | 119 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0751523 | |
| Disease | Petit mal status | 2.54e-03 | 67 | 119 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0393734 | |
| Disease | diet measurement, HOMA-B | 2.64e-03 | 19 | 119 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.64e-03 | 19 | 119 | 2 | EFO_0004630, HP_0002140 | |
| Disease | Status Epilepticus | 2.65e-03 | 68 | 119 | 3 | C0038220 | |
| Disease | lifestyle measurement | 2.69e-03 | 235 | 119 | 5 | EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IRNNSITTEGNIIVY | 826 | Q8NHU2 | |
| ISIVLSVYDLRQQSV | 236 | Q4VNC0 | |
| IVALNTGVSILYTLT | 1321 | Q9P2K9 | |
| YTIDLNSILTVPLQS | 256 | O42043 | |
| LSTALRQSVLQIYTS | 156 | Q6ZNB7 | |
| VSVNVTQERQYITSL | 241 | Q8IUA7 | |
| TPSVIYTINLVVTDL | 86 | Q99678 | |
| LRSILGTLTVEQIYQ | 111 | Q14254 | |
| VSTIQITTAIPNTVY | 361 | Q9NZU0 | |
| LVQTIIILESSQVRY | 3351 | Q8WXG9 | |
| QTVLSTYLRPLQTSE | 291 | Q14155 | |
| RLNVSQLTINTAIVY | 51 | O60563 | |
| QEQIYLNRTLLTTIS | 1281 | Q9NYQ6 | |
| YITSLFQVLPQQVSI | 231 | P11532 | |
| TQGLQIFILYTVRTK | 711 | Q96K78 | |
| INLIYTIGRTVTTDL | 926 | Q6Q4G3 | |
| KGQVLVLRTTSTVYN | 446 | P19801 | |
| YLQIRSSVIIIQARS | 2906 | Q8IZT6 | |
| NGNQSRVILYTITLT | 421 | Q3KR37 | |
| LLYRITNAQNITVIV | 396 | Q9UPM8 | |
| LSPTVQISNRVLYVF | 346 | Q15311 | |
| SLYLSAQLQIGVIRV | 66 | O95072 | |
| IQAAYIGTTIIIRQT | 276 | Q6ZVN8 | |
| AVVYSNTIQSIIAII | 71 | P63096 | |
| PIVYTSQNVALQLTL | 201 | Q63HM1 | |
| SLEYTQILQTVRIPS | 666 | Q92621 | |
| TYNLTVQILNITISS | 1086 | Q9HCM3 | |
| TVILRISKTQLYVTA | 181 | P01583 | |
| LYVTILTQQARLSLV | 131 | Q8NGQ5 | |
| CTIVIIVQYLNTTEQ | 141 | O15552 | |
| AVIYSNTLQSILAIV | 71 | A8MTJ3 | |
| TRVGVIQYSSQVQSV | 71 | O95460 | |
| RTVTIYLTIKTNSLN | 2171 | Q5T1H1 | |
| VVVYSNTIQSIIAII | 71 | P08754 | |
| PRVVLLSNTQTQYSI | 86 | Q9P121 | |
| TRLSPTVILDNQVTY | 216 | Q13201 | |
| LQTTSQYLIRNVETT | 201 | Q9NU53 | |
| VTTERTIQLNVTYVP | 221 | P20138 | |
| QVLNLVQSYVTLRVP | 2661 | Q5SZK8 | |
| TRLLQILAITTGTYA | 1816 | Q15751 | |
| IYRVTSQQDSSVLQV | 671 | A6NKB5 | |
| ATTVTYPLQTVQSIL | 216 | O43808 | |
| NPLRYTSVLTNTRVV | 126 | Q9H339 | |
| ISYTIILVTVRQRSS | 216 | Q96R72 | |
| SPVVLASYARNQTLV | 86 | P43116 | |
| PVLSVAAQQIYIVLT | 1906 | Q96JB1 | |
| ILLYISQQQPVTVAR | 111 | Q5T1M5 | |
| NVAVPIATYSVVQLR | 56 | Q6NV75 | |
| VAQTISYEVTLAIIL | 136 | P03886 | |
| QLTPVLVSVVTFSVY | 551 | Q92887 | |
| TVLLYLDSNQITSIP | 66 | Q96PB8 | |
| PQLVQLVLYTSQTAL | 566 | Q9Y4D8 | |
| TVTDLVEYSIVIQQL | 326 | P39656 | |
| LTYVLSVTGNLTIIS | 31 | A6NM76 | |
| ITTVIQRIFYTVNRS | 846 | Q06190 | |
| PYLQTVSVSVSVLTL | 131 | O43614 | |
| VFTVTQTGITRYLTL | 451 | Q96QU1 | |
| NYTILFTVSIRNTLL | 151 | P36888 | |
| TSTLVAFLQQVLTYQ | 2371 | Q8NCM8 | |
| LTQATRTTVYIVDIQ | 1071 | Q9BYE9 | |
| RLLTSNIIVTTVQYL | 1001 | Q8IZD9 | |
| SRQVQVLQNLTTTYE | 36 | Q96IY4 | |
| EISPNRVQISLVQYS | 471 | Q99715 | |
| GSLLILVVIRTIQYN | 436 | Q7RTS9 | |
| TTPIYILRIQATNNE | 531 | Q6ZTQ4 | |
| ILISAISQSTLIYEV | 1691 | Q8TDW7 | |
| PITYLEVINTVAQVT | 181 | O15121 | |
| VTVSYQVITSLLLGT | 31 | P08908 | |
| VILTNTIYNQSTVVS | 96 | Q9Y5Q5 | |
| TLGYTISRETQNLQV | 261 | Q9H819 | |
| SSVLTIYDIGIQTNI | 301 | Q8NCS7 | |
| NSSVQNRTYIVTTIL | 401 | P42261 | |
| QTLYTSLCTLVQRVG | 171 | Q969P5 | |
| IISSIVPSTQDIYQR | 2006 | Q9C0D2 | |
| YTNQTTQVVPLRAVV | 1616 | Q9Y238 | |
| YLRTQTGNTTTINII | 3901 | P21817 | |
| TTVNIIISTVDYLLR | 3866 | Q92736 | |
| AVLVLSVTTQINYLN | 281 | Q6NVV3 | |
| TITTITNILALYTGI | 491 | Q3KNS1 | |
| ENYILRATTIGQTTL | 1046 | Q5VU65 | |
| VYRLQVSSINVSVNA | 206 | P09619 | |
| RIATINYTVLTSVLN | 271 | Q8NH93 | |
| QNSLQDRLISVTYTV | 266 | P0C629 | |
| TILNLTIYIILTTTA | 201 | P03891 | |
| TQVTTYLTALQISNP | 76 | Q6ZR62 | |
| NVTSLRGVYITSVLS | 406 | Q99523 | |
| ALPVVQLVITYQTVV | 461 | Q8NBJ9 | |
| LVRAVSIQTGYLIQS | 161 | Q9Y365 | |
| TTSLYRAQQIIQLNI | 286 | Q9BX59 | |
| QPVTVYVSVFTLTTI | 141 | P49683 | |
| KRNSIYVTVTLLIVS | 26 | Q5JRV8 | |
| YQIVVEIIQATTISS | 201 | Q9H3E2 | |
| IILSNVIPYLETISN | 461 | Q96RN1 | |
| AVIIALLTVIYRTQS | 491 | P58743 | |
| TLVESRTINVSNLYV | 2611 | P25391 | |
| PVVYSNTIQSLAAIV | 71 | P09471 | |
| TVSQSLPVLSTLQLY | 1341 | Q96Q15 | |
| YVTQINRLLSTITEP | 1096 | Q8TCU6 | |
| RTVQLNVSYAPQTIT | 226 | O15389 | |
| SVINYDLNQVITTTV | 2081 | Q9UKZ4 | |
| TATRTYQTIIELFIQ | 1416 | Q9NRY4 | |
| TYILSVTGNLTIITL | 31 | Q9NZP0 | |
| LIPTIVSNAYIISTI | 211 | Q8NGU2 | |
| TIRTYLTITDTQLVN | 716 | Q5JTH9 | |
| LVQLFSTVSVQYVPT | 306 | Q86UX6 | |
| PTYTNLNRLISQIVS | 161 | Q9H853 | |
| TSIIQGALTQLIQLY | 671 | Q8N1B4 | |
| LSLYLVTVNTDLTTI | 206 | Q5BJH7 | |
| ITTNNSITGIVLYVV | 156 | Q9H900 | |
| TYLRVSTVTVLAQSL | 341 | Q6ZTK2 | |
| RLTQVSVLQYGSITT | 1726 | P04275 | |
| LVLTAQTYNASPVIS | 2886 | Q96T58 | |
| SYAVILVSLRQQISK | 221 | P0C645 | |
| VSRTVQQVINLVYTT | 136 | Q7RTY8 | |
| IQTLIQGTQTRLKYS | 701 | Q8NDV3 | |
| EVTITIGLRYLQTSL | 276 | P23942 | |
| VSQNINYTTVALLPI | 2986 | Q15413 | |
| SDVYSILQSIPQRQI | 371 | Q93063 | |
| RGLTYITISLNISII | 436 | Q71RS6 | |
| LLERSTITSVYQNSV | 746 | P37275 | |
| LYQTSLTTLTQIRLQ | 466 | Q7Z3V4 | |
| VTNRLYTLVSTLTVQ | 316 | Q6NXT4 | |
| VQVTALYVTRLDNVT | 446 | Q04912 | |
| ISRIAVSYQTKVNLL | 156 | P01375 | |
| QVSSINPTVTRSLLY | 86 | Q9P2D8 | |
| NKTINSRIGNTVYIT | 1191 | P82987 |